Gowling WLG’s patent litigation team represents life sciences innovators in complex, high-stakes disputes involving some of their most valuable products and technologies. Combining deep technical knowledge with strategic litigation experience, the team helps clients protect and enforce the intellectual property at the heart of their businesses.

That strength has been recognized at the 2026 LMG Life Sciences Americas Awards, where Gowling WLG was named Patent Litigation Firm of the Year – Canada. Our patent litigation team was also awarded with the Patent Impact Case of the Year – Canada award for Apotex v Eli Lilly and Company (2025 ONCA 176). 

Gowling WLG was also shortlisted in two additional Canadian categories:

  • Patent Litigator of the Year – Canada: Marc Richard
  • Patent Strategy Firm of the Year – Canada: Gowling WLG

Gowling WLG partner Marc Richard at the LMG Life Sciences Americas Awards 2026.

The LMG Life Sciences Americas Awards recognize leading law firms, lawyers, and in-house teams across the United States, Canada and Brazil for their work in the life sciences sector over the past year. The awards are informed by extensive research and submissions, with a focus on the practitioners and firms behind the region’s most significant cases, transactions and other mandates.

About Gowling WLG's Life Sciences Group

Whether working with biotech startups, research organizations or large pharmaceutical companies, Gowling WLG's team has the depth of life sciences experience clients look for. By engaging us, you'll gain access to advice on all relevant legal issues from professionals who are immersed in your sector and can guide you through every stage of your products' life cycles, as well as your company's development. Learn more about Gowling WLG's Life Sciences Group.